tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RMD Stock Latest News

Morgan Stanley sees ‘modest’ earnings impact to ResMed from Apnimed
The FlyMorgan Stanley sees ‘modest’ earnings impact to ResMed from Apnimed
1M ago
RMD
Apnimed data brings competitive threat to ResMed, says RBC Capital
PremiumThe Fly
Apnimed data brings competitive threat to ResMed, says RBC Capital
1M ago
RMD
Resmed’s Growth Potential Highlighted by Promising Trial Results and Future Opportunities
PremiumRatings
Resmed’s Growth Potential Highlighted by Promising Trial Results and Future Opportunities
1M ago
RMD
Buy Rating for Resmed: Positive Phase 3 Trial Results and Market Conditions Boost AD109’s Appeal
PremiumRatings
Buy Rating for Resmed: Positive Phase 3 Trial Results and Market Conditions Boost AD109’s Appeal
1M ago
RMD
GOOGL, RMD: TipRanks’ New AI Analyst Tool Reveals 2 Stocks for Potential Growth
PremiumMarket News
GOOGL, RMD: TipRanks’ New AI Analyst Tool Reveals 2 Stocks for Potential Growth
1M ago
RMD
ResMed named Sleep Partner of the Qatar Airways British & Irish Lions Tour
PremiumThe FlyResMed named Sleep Partner of the Qatar Airways British & Irish Lions Tour
2M ago
RMD
ResMed announces it has acquired VirtuOx
Premium
The Fly
ResMed announces it has acquired VirtuOx
2M ago
RMD
ResMed Inc’s Earnings Call Highlights Growth and Innovation
Premium
Company Announcements
ResMed Inc’s Earnings Call Highlights Growth and Innovation
2M ago
RMD
Early notable gainers among liquid option names on April 24th
PremiumThe Fly
Early notable gainers among liquid option names on April 24th
2M ago
HAS
NOW
ResMed price target lowered to $285 from $290 at UBS
PremiumThe Fly
ResMed price target lowered to $285 from $290 at UBS
2M ago
RMD
ResMed price target lowered to $250 from $265 at Mizuho
PremiumThe Fly
ResMed price target lowered to $250 from $265 at Mizuho
2M ago
RMD
ResMed price target lowered to $248 from $260 at Piper Sandler
PremiumThe Fly
ResMed price target lowered to $248 from $260 at Piper Sandler
2M ago
RMD
ResMed price target raised to $255 from $247 at RBC Capital
PremiumThe FlyResMed price target raised to $255 from $247 at RBC Capital
2M ago
RMD
ResMed: Strong Financial Performance and Strategic Positioning Justify Buy Rating
Premium
Ratings
ResMed: Strong Financial Performance and Strategic Positioning Justify Buy Rating
2M ago
RMD
ResMed price target raised to $274 from $269 at KeyBanc
Premium
The Fly
ResMed price target raised to $274 from $269 at KeyBanc
2M ago
RMD
Resmed’s Strong Q3 Performance and Strategic Positioning Justify Buy Rating
PremiumRatings
Resmed’s Strong Q3 Performance and Strategic Positioning Justify Buy Rating
2M ago
RMD
Resmed Inc. Reports Strong Q3 2025 Earnings
PremiumCompany Announcements
Resmed Inc. Reports Strong Q3 2025 Earnings
2M ago
RMD
Closing Bell Movers: Robert Half down 15% after earnings miss
PremiumThe Fly
Closing Bell Movers: Robert Half down 15% after earnings miss
2M ago
EW
PI
ResMed reports Q3 non-GAAP EPS $2.37, consensus $2.36
PremiumThe Fly
ResMed reports Q3 non-GAAP EPS $2.37, consensus $2.36
2M ago
RMD
ResMed appoints Salli Schwartz as Chief Investor Relations Officer
PremiumThe FlyResMed appoints Salli Schwartz as Chief Investor Relations Officer
2M ago
RMD
ResMed price target lowered to $268 from $280 at KeyBanc
Premium
The Fly
ResMed price target lowered to $268 from $280 at KeyBanc
2M ago
RMD
RMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
RMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
RMD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >